166 related articles for article (PubMed ID: 19273079)
1. PML links aberrant cytokine signaling and oncogenic stress to cellular senescence.
Bourdeau V; Baudry D; Ferbeyre G
Front Biosci (Landmark Ed); 2009 Jan; 14(2):475-85. PubMed ID: 19273079
[TBL] [Abstract][Full Text] [Related]
2. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways.
Bischof O; Nacerddine K; Dejean A
Mol Cell Biol; 2005 Feb; 25(3):1013-24. PubMed ID: 15657429
[TBL] [Abstract][Full Text] [Related]
5. Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence.
Mallette FA; Goumard S; Gaumont-Leclerc MF; Moiseeva O; Ferbeyre G
Oncogene; 2004 Jan; 23(1):91-9. PubMed ID: 14712214
[TBL] [Abstract][Full Text] [Related]
6. Regulation of E2Fs and senescence by PML nuclear bodies.
Vernier M; Bourdeau V; Gaumont-Leclerc MF; Moiseeva O; Bégin V; Saad F; Mes-Masson AM; Ferbeyre G
Genes Dev; 2011 Jan; 25(1):41-50. PubMed ID: 21205865
[TBL] [Abstract][Full Text] [Related]
7. Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci.
Ye X; Zerlanko B; Zhang R; Somaiah N; Lipinski M; Salomoni P; Adams PD
Mol Cell Biol; 2007 Apr; 27(7):2452-65. PubMed ID: 17242198
[TBL] [Abstract][Full Text] [Related]
8. The retinoblastoma protein and PML collaborate to organize heterochromatin and silence E2F-responsive genes during senescence.
Talluri S; Dick FA
Cell Cycle; 2014; 13(4):641-51. PubMed ID: 24351540
[TBL] [Abstract][Full Text] [Related]
9. DAXX silencing suppresses mouse ovarian surface epithelial cell growth by inducing senescence and DNA damage.
Pan WW; Yi FP; Cao LX; Liu XM; Shen ZF; Bu YQ; Xu Y; Fan HY; Song FZ
Gene; 2013 Sep; 526(2):287-94. PubMed ID: 23542781
[TBL] [Abstract][Full Text] [Related]
10. PML is induced by oncogenic ras and promotes premature senescence.
Ferbeyre G; de Stanchina E; Querido E; Baptiste N; Prives C; Lowe SW
Genes Dev; 2000 Aug; 14(16):2015-27. PubMed ID: 10950866
[TBL] [Abstract][Full Text] [Related]
11. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
[TBL] [Abstract][Full Text] [Related]
12. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.
Pearson M; Carbone R; Sebastiani C; Cioce M; Fagioli M; Saito S; Higashimoto Y; Appella E; Minucci S; Pandolfi PP; Pelicci PG
Nature; 2000 Jul; 406(6792):207-10. PubMed ID: 10910364
[TBL] [Abstract][Full Text] [Related]
13. Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence.
Scaglioni PP; Rabellino A; Yung TM; Bernardi R; Choi S; Konstantinidou G; Nardella C; Cheng K; Pandolfi PP
EMBO Mol Med; 2012 Jul; 4(7):594-602. PubMed ID: 22359342
[TBL] [Abstract][Full Text] [Related]
14. Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.
Song H; Boo JH; Kim KH; Kim C; Kim YE; Ahn JH; Jeon GS; Ryu H; Kang DE; Mook-Jung I
Cell Death Differ; 2013 Apr; 20(4):639-48. PubMed ID: 23306558
[TBL] [Abstract][Full Text] [Related]
15. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion.
Rodier F; Muñoz DP; Teachenor R; Chu V; Le O; Bhaumik D; Coppé JP; Campeau E; Beauséjour CM; Kim SH; Davalos AR; Campisi J
J Cell Sci; 2011 Jan; 124(Pt 1):68-81. PubMed ID: 21118958
[TBL] [Abstract][Full Text] [Related]
16. ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence.
Fausti F; Di Agostino S; Cioce M; Bielli P; Sette C; Pandolfi PP; Oren M; Sudol M; Strano S; Blandino G
Cell Death Differ; 2013 Nov; 20(11):1498-509. PubMed ID: 23933816
[TBL] [Abstract][Full Text] [Related]
17. PML is a direct p53 target that modulates p53 effector functions.
de Stanchina E; Querido E; Narita M; Davuluri RV; Pandolfi PP; Ferbeyre G; Lowe SW
Mol Cell; 2004 Feb; 13(4):523-35. PubMed ID: 14992722
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor PML specifically accumulates at RPA/Rad51-containing DNA damage repair foci but is nonessential for DNA damage-induced fibroblast senescence.
Münch S; Weidtkamp-Peters S; Klement K; Grigaravicius P; Monajembashi S; Salomoni P; Pandolfi PP; Weißhart K; Hemmerich P
Mol Cell Biol; 2014 May; 34(10):1733-46. PubMed ID: 24615016
[TBL] [Abstract][Full Text] [Related]
19. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
20. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
